Aligning Science Across Parkinson's Logo Text

Colleen Niswender, PhD

Co-PI (Core Leadership)

Colleen is an Associate Professor and the Warren and Senior Director of Molecular Pharmacology for the Warren Center of Neuroscience Drug Discovery at Vanderbilt University. She has been involved in the development of five compounds which have progressed into clinical trials for schizophrenia, Alzheimer’s disease, and Parkinson’s disease. Her scientific goal is to work with teams that successfully launch drugs to impact one or several neurological, neurodevelopmental, or psychiatric diseases.

Vanderbilt University | USA
Co-PI (Core Leadership)

Colleen Niswender, PhD

Vanderbilt University

Colleen is an Associate Professor and the Warren and Senior Director of Molecular Pharmacology for the Warren Center of Neuroscience Drug Discovery at Vanderbilt University. She has been involved in the development of five compounds which have progressed into clinical trials for schizophrenia, Alzheimer’s disease, and Parkinson’s disease. Her scientific goal is to work with teams that successfully launch drugs to impact one or several neurological, neurodevelopmental, or psychiatric diseases.

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.